Cargando…
ESMO Open special series on new emerging targets in cancer immunotherapy
Autor principal: | Lambertini, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326248/ https://www.ncbi.nlm.nih.gov/pubmed/32376765 http://dx.doi.org/10.1136/esmoopen-2020-000795 |
Ejemplares similares
-
ESMO Open: news in breast cancer 2019
por: Lambertini, Matteo
Publicado: (2020) -
ESMO Leaders Generation Programme: an alumni insight
por: Arruda, Leticia De Mattos, et al.
Publicado: (2018) -
ESMO20 YO for YO: highlights on new drugs in advanced breast cancer focusing on sacituzumab govitecan and alpelisib
por: Lambertini, M., et al.
Publicado: (2020) -
ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer
por: Matikas, A., et al.
Publicado: (2020) -
ESMO-Magnitude of Clinical Benefit Scale (MCBS) group
por: Amaral, Teresa
Publicado: (2019)